Projects per year
Personal profile
Education/Academic qualification
Bachelor
Fingerprint
Dive into the research topics where Mourad Gumusboga is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
TriDoRe: Novel High-Dose Tuberculosis Retreatment Regimens: How to overcome resistance without creating more?
Lynen, L., de Jong, B., Van Deun, A., Decroo, T., Gumusboga, M., Meehan, C., Lempens, P., Rigouts, L., Van Herrewege, Y., Buyze, J., Herssens, N. & Vlaminck, A.
1/10/18 → 30/09/24
Project: Research Project
-
BENIN - 2018 - FA4: Institutional strengthening of the Mycobacteria Reference Laboratory (LRM, Bénin) for quality services and better quality of health care for Mycobacteria and other clinical bacteria, at National and Regional Level.
de Jong, B., Jacobs, J., Hardy, L., Stassijns, J., Nduwamahoro, E., Eddyani, M., Gumusboga, M. & Janssens, N.
Directorate-General for Development Cooperation and Humanitarian Aid
1/01/18 → 31/12/18
Project: Development project
Research output
-
Acquired rifampicin resistance during first TB treatment: magnitude, relative importance, risk factors and keys to control in low-income settings
Van Deun, A., Bola, V., Lebeke, R., Kaswa, M., Hossain, M. A., Gumusboga, M., Torrea, G., De Jong, B. C., Rigouts, L. & Decroo, T., 2022, In: JAC-Antimicrobial Resistance. 4, 2, 9 p., dlac037.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open AccessFile18 Downloads (Pure) -
Bedaquiline can act as core drug in a standardized treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis
Decroo, T., Jai, K., Aung, M., Hossain, M. A., Gumusboga, M., Ortuno-Gutierrez, N., de Jong, B. C. & Van Deun, A., 2021, (E-pub ahead of print) In: European Respiratory Journal. 59, 3, 2102124.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open AccessFile2 Downloads (Pure) -
Finding the right balance between efficacy and tolerability for TB treatment: the search continues
Maug, A. K. J., Hossain, M. A., Gumusboga, M., Decroo, T., Mulders, W., Braet, S., Buyze, J., Jiménez, D. A., Schurmans, C., Herssens, N., Demeulenaere, T., Lynen, L., de Jong, B. C. & Van Deun, A., 2021, In: International Journal of Tuberculosis and Lung Disease. 25, 1, p. 84-86 3 p.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open AccessFile7 Downloads (Pure) -
Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown
Van Deun, A., Decroo, T., Aung, K. J. M., Hossain, M. A., Gumusboga, M., De Rijk, W. B., Tahseen, S., de Jong, B. C. & Rigouts, L., 2021, In: European Respiratory Journal. 58, 3, 2100783.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open AccessFile1 Downloads (Pure) -
The simple direct slide method is comparable to indirect Lowenstein Jensen proportion culture for detecting rifampicin resistant tuberculosis
Achan, B., Asiimwe, B. B., Joloba, M. L., Gumusboga, M., Ssengooba, W. & Bwanga, F., 2021, In: Journal of Medical Microbiology. 70, 3, 5 p., 001331.Research output: Contribution to journal › A1: Web of Science-article › peer-review